NO20031830L - Polysubstituerte imidazopyridiner som gastriske sekresjonshemmere - Google Patents
Polysubstituerte imidazopyridiner som gastriske sekresjonshemmereInfo
- Publication number
- NO20031830L NO20031830L NO20031830A NO20031830A NO20031830L NO 20031830 L NO20031830 L NO 20031830L NO 20031830 A NO20031830 A NO 20031830A NO 20031830 A NO20031830 A NO 20031830A NO 20031830 L NO20031830 L NO 20031830L
- Authority
- NO
- Norway
- Prior art keywords
- gastric secretion
- secretion inhibitors
- imidazopyridines
- polysubstituted
- polysubstituted imidazopyridines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00123133 | 2000-10-25 | ||
| PCT/EP2001/012207 WO2002034749A1 (en) | 2000-10-25 | 2001-10-23 | Polysubstituted imidazopyridines as gastric secretion inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20031830D0 NO20031830D0 (no) | 2003-04-24 |
| NO20031830L true NO20031830L (no) | 2003-04-24 |
| NO325736B1 NO325736B1 (no) | 2008-07-14 |
Family
ID=8170193
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20031830A NO325736B1 (no) | 2000-10-25 | 2003-04-24 | Polysubstituerte imidazopyridiner samt anvendelse derav til fremstillinig av medikamenter som gastriske sekresjonshemmere |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US6869949B2 (no) |
| EP (1) | EP1332143A1 (no) |
| JP (1) | JP2004512338A (no) |
| KR (1) | KR20040011423A (no) |
| CN (1) | CN1692113A (no) |
| AU (2) | AU1056302A (no) |
| BR (1) | BR0114873A (no) |
| CA (1) | CA2426616A1 (no) |
| EA (1) | EA008151B1 (no) |
| HR (1) | HRP20030323A2 (no) |
| HU (1) | HUP0302308A2 (no) |
| IL (1) | IL154850A0 (no) |
| MX (1) | MXPA03003706A (no) |
| NO (1) | NO325736B1 (no) |
| NZ (1) | NZ525281A (no) |
| PL (1) | PL360412A1 (no) |
| SK (1) | SK5072003A3 (no) |
| WO (1) | WO2002034749A1 (no) |
| ZA (1) | ZA200302038B (no) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6869949B2 (en) * | 2000-10-25 | 2005-03-22 | Altana Pharma Ag | Polysubstituted imidazopyridines as gastric secretion inhibitors |
| DE10145457A1 (de) * | 2001-09-14 | 2003-04-03 | Basf Ag | Substituierte Imidazo[1,2-a]-5,6,7,8-tetrahydropyridin-8-one, Verfahren zu ihrer Herstellung, sowie deren Verwendung zur Herstellung von Imidazo[1,2,-a]pyridinen |
| MXPA04007895A (es) | 2002-02-15 | 2004-10-15 | Altana Pharma Ag | Compuestos n-acilo triciclicos. |
| TWI295575B (en) * | 2002-04-24 | 2008-04-11 | Altana Pharma Ag | Nitrosated imidazopyridines |
| BR0316752A (pt) * | 2002-12-20 | 2005-10-25 | Altana Pharma Ag | Silil éteres |
| MXPA05008490A (es) * | 2003-02-17 | 2005-10-18 | Altana Pharma Ag | Combinaciones que contienen imidazopiridinas y su uso en el tratamiento de enfermedades gastrointestinales inflamatorias. |
| US20060194972A1 (en) * | 2003-04-03 | 2006-08-31 | Altana Pharma Ag | Process for the production of imidazopyridin-8-ones |
| AR044129A1 (es) * | 2003-05-06 | 2005-08-24 | Altana Pharma Ag | Compuestos intermedios de imidazopiridina. proceso de preparacion. |
| EP1974730A1 (en) | 2003-11-03 | 2008-10-01 | AstraZeneca AB | Imidazo[1,2-a]pyridine derivatives for use in the treatment of sleep disturbance due to silent gastro-esophageal reflux |
| AR046893A1 (es) * | 2003-12-16 | 2005-12-28 | Altana Pharma Ag | Bencimidazoles triciclicos |
| AR046941A1 (es) * | 2003-12-19 | 2006-01-04 | Altana Pharma Ag | Imidazopiridinas triciclicas y su uso como inhibidores de secrecion de acido gastrico |
| AU2004298453A1 (en) | 2003-12-19 | 2005-06-30 | Altana Pharma Ag | Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives |
| CA2582256A1 (en) * | 2004-10-01 | 2006-04-13 | Altana Pharma Ag | Substituted tricyclic benzimidazoles |
| AR051375A1 (es) * | 2004-10-15 | 2007-01-10 | Altana Pharma Ag | Imidazopiridinas difluoro substituidas |
| WO2008058990A1 (en) * | 2006-11-16 | 2008-05-22 | Nycomed Gmbh | 7,7-disubstituted pyrano-[2,3-c]-imidazo-[1,2-a]-pyridine derivatives and their use as gastric acid secretion inhibitors |
| WO2012027240A1 (en) * | 2010-08-23 | 2012-03-01 | Schering Corporation | Fused tricyclic inhibitors of mammalian target of rapamycin |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4468400A (en) * | 1982-12-20 | 1984-08-28 | Schering Corporation | Antiulcer tricyclic imidazo [1,2-a]pyridines |
| US4673679A (en) * | 1986-05-14 | 1987-06-16 | E. I. Du Pont De Nemours And Company | Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration |
| WO1992021341A1 (en) * | 1991-05-31 | 1992-12-10 | Pfizer Inc. | Use of rapamycin prodrugs as immunosuppressant agents |
| DE4308095A1 (de) * | 1993-03-13 | 1994-09-15 | Hoechst Ag | Prodrug-Derivate von Arzneimittelwirkstoffen mit Hydroxylgruppen, Verfahren zu deren Herstellung und ihre Verwendung |
| SE9401197D0 (sv) | 1994-04-11 | 1994-04-11 | Astra Ab | Active compounds |
| PT971922E (pt) * | 1997-03-24 | 2004-09-30 | Altana Pharma Ag | Compostos de tetra-hidropirido |
| WO1998042707A1 (en) * | 1997-03-24 | 1998-10-01 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Tetrahydropyrido compounds |
| ZA982445B (en) * | 1997-03-24 | 1998-09-24 | Byk Gulden Lomberg Chem Fab | Tetrahydropyrido compounds |
| WO1998054188A1 (en) * | 1997-05-28 | 1998-12-03 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Fused dihydropyrans |
| EA005377B1 (ru) * | 1998-09-23 | 2005-02-24 | Алтана Фарма Аг | ТЕТРАГИДРОИМИДАЗО [1,2-h][1,7] НАФТИРИДИНОВЫЕ СОЕДИНЕНИЯ |
| JP2002528548A (ja) * | 1998-11-03 | 2002-09-03 | ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング | イミダゾナフチリジン |
| DK1173439T3 (da) * | 1999-04-17 | 2003-09-08 | Altana Pharma Ag | Halogenalkoxy-imidazonaphthyridiner |
| AU783764B2 (en) * | 2000-03-29 | 2005-12-01 | Altana Pharma Ag | Alkylated imidazopyridine derivatives |
| WO2001072755A1 (en) * | 2000-03-29 | 2001-10-04 | Altana Pharma Ag | Pyrano[2,3-c]imidazo[-1,2-a]pyridine derivatives for the treatment of gastrointestinal disorders |
| IL151200A0 (en) * | 2000-03-29 | 2003-04-10 | Altana Pharma Ag | Tricyclic imidazopyridine prodrug derivatives and pharmaceutical compositions containing the same |
| AU783724B2 (en) * | 2000-03-29 | 2005-12-01 | Altana Pharma Ag | Tricyclic imidazopyridines |
| US6869949B2 (en) * | 2000-10-25 | 2005-03-22 | Altana Pharma Ag | Polysubstituted imidazopyridines as gastric secretion inhibitors |
-
2001
- 2001-10-23 US US10/380,624 patent/US6869949B2/en not_active Expired - Fee Related
- 2001-10-23 BR BR0114873-7A patent/BR0114873A/pt not_active IP Right Cessation
- 2001-10-23 CA CA002426616A patent/CA2426616A1/en not_active Abandoned
- 2001-10-23 SK SK507-2003A patent/SK5072003A3/sk not_active Application Discontinuation
- 2001-10-23 IL IL15485001A patent/IL154850A0/xx unknown
- 2001-10-23 NZ NZ525281A patent/NZ525281A/en unknown
- 2001-10-23 EP EP01978447A patent/EP1332143A1/en not_active Withdrawn
- 2001-10-23 EA EA200300478A patent/EA008151B1/ru not_active IP Right Cessation
- 2001-10-23 WO PCT/EP2001/012207 patent/WO2002034749A1/en active IP Right Grant
- 2001-10-23 JP JP2002537739A patent/JP2004512338A/ja active Pending
- 2001-10-23 AU AU1056302A patent/AU1056302A/xx active Pending
- 2001-10-23 HU HU0302308A patent/HUP0302308A2/hu unknown
- 2001-10-23 PL PL36041201A patent/PL360412A1/xx not_active Application Discontinuation
- 2001-10-23 AU AU2002210563A patent/AU2002210563B2/en not_active Ceased
- 2001-10-23 KR KR10-2003-7005620A patent/KR20040011423A/ko not_active Application Discontinuation
- 2001-10-23 CN CNA018177808A patent/CN1692113A/zh active Pending
- 2001-10-23 MX MXPA03003706A patent/MXPA03003706A/es active IP Right Grant
-
2003
- 2003-03-13 ZA ZA200302038A patent/ZA200302038B/en unknown
- 2003-04-24 HR HR20030323A patent/HRP20030323A2/hr not_active Application Discontinuation
- 2003-04-24 NO NO20031830A patent/NO325736B1/no unknown
-
2004
- 2004-05-24 US US10/851,092 patent/US7141567B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EA200300478A1 (ru) | 2003-12-25 |
| SK5072003A3 (en) | 2003-09-11 |
| NO325736B1 (no) | 2008-07-14 |
| AU2002210563B2 (en) | 2007-03-01 |
| WO2002034749A1 (en) | 2002-05-02 |
| JP2004512338A (ja) | 2004-04-22 |
| US20040214852A1 (en) | 2004-10-28 |
| HUP0302308A2 (hu) | 2003-11-28 |
| EA008151B1 (ru) | 2007-04-27 |
| US7141567B2 (en) | 2006-11-28 |
| NO20031830D0 (no) | 2003-04-24 |
| US6869949B2 (en) | 2005-03-22 |
| KR20040011423A (ko) | 2004-02-05 |
| IL154850A0 (en) | 2003-10-31 |
| EP1332143A1 (en) | 2003-08-06 |
| CA2426616A1 (en) | 2002-05-02 |
| ZA200302038B (en) | 2004-04-22 |
| PL360412A1 (en) | 2004-09-06 |
| CN1692113A (zh) | 2005-11-02 |
| BR0114873A (pt) | 2003-07-01 |
| US20040106642A1 (en) | 2004-06-03 |
| HRP20030323A2 (hr) | 2005-04-30 |
| NZ525281A (en) | 2004-11-26 |
| AU1056302A (en) | 2002-05-06 |
| MXPA03003706A (es) | 2005-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20005450D0 (no) | Imidazopyridinderivater som inhiberer magesyresekresjon | |
| NO20030055L (no) | Colchinolderivater som angiogenese inhibitorer | |
| NO20023828L (no) | Pyrimidin-4-on derivater som LDL-PLA2 inhibitorer | |
| NO20021239D0 (no) | Pteridinoner som kinase-inhibitorer | |
| CY2014018I1 (el) | Kαρβαμιδο - υποκατεστημενες πυραζολοπυριδινες | |
| NO20012337L (no) | Fremgangsmåte for sementering av underjordiske soner | |
| NO20030867L (no) | Hydroksamderivater anvendelig som deacetylaseinhibitorer | |
| EE200300273A (et) | Asendatud imidasopüridiinid | |
| NO20041887L (no) | Benzomidazoler anvendelige som proteinkinase-inhibitorer | |
| NO20031450L (no) | Fumarsyrederivater som NF-kappa B inhibitorer | |
| DK1140840T3 (da) | omega-carboxyaryl-substituerede diphenylurinstoffer som raf-kinase-inhibitorer | |
| DK1289985T3 (da) | Beta-carbolinderivater anvendelige som phosphodiesteraseinhibitorer | |
| DK2253620T3 (da) | Substituerede 3-cyanoquinoliner som protein-tyrosinkinase-inhibitorer | |
| NO20022139L (no) | Kinazolinderivater som VEGF inhibitorer | |
| NO20031830D0 (no) | Polysubstituerte imidazopyridiner som gastriske sekresjonshemmere | |
| NO20014483D0 (no) | Aminderivater som proteaseinhibitorer | |
| NO20015065L (no) | Pyrazolobenzodiazepiner som CDK2-inhibitorer | |
| NO20050563L (no) | N-aryl-piperidinsubstituerte bifenylkarboksamider som inhibitorer av apolipoprotein B-sekresjon | |
| NO20014675L (no) | Fremgangsmåter for sementering i underjordiske soner | |
| FI20002884A0 (fi) | Elastomeerien polyalfaolefiinipehmittimet | |
| NO20016201D0 (no) | Tienopyrimidiner som fosfodiesteraseinhibitorer | |
| PT1339695E (pt) | Inibidores da farnesiltransferase | |
| FI20020884A0 (fi) | Porausmenetelmä | |
| DK1690853T3 (da) | Omega-carboxyaryl-substituerede diphenylurinstoffer til anvendelse som raf-kinaseinhibitorer | |
| DE50104434D1 (de) | Lactam-substituierte pyrazolopyridinderivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CREP | Change of representative |
Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104 |